Page 2 - Ivir News Today

Vir Biotechnology (NASDAQ:VIR – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.14) by $0.28, Briefing.com reports. Vir Biotechnology had a negative return on equity of 33.82% and a negative net margin of 713.69%. The business had […]

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) rose 8.5% on Friday after the company announced better than expected quarterly earnings. The stock traded as high as $11.28 and last traded at $11.18. Approximately 290,356 shares changed hands during trading, a decline of 73% from the average daily volume of 1,084,488 shares. The stock had […]

By Sabela Ojea Vir Biotechnology said Chief Medical Officer Phil Pang will be leaving the company at the end of March. The immunology company on Tuesday said...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages […]

Vir Biotechnology (NASDAQ:VIR – Free Report) had its price objective trimmed by HC Wainwright from $95.00 to $85.00 in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Vir Biotechnology’s Q1 2024 earnings at ($0.99) EPS, Q2 2024 […]

Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for Vir Biotechnology in a report issued on Tuesday, January 23rd. HC Wainwright analyst P. Trucchio expects that the company will post earnings per share of ($0.56) for the year. HC Wainwright has a “Buy” […]

Viridium Pacific Group Ltd (CVE:VIR – Get Free Report)’s stock price shot up 5.6% during mid-day trading on Wednesday . The stock traded as high as C$0.41 and last traded at C$0.38. 26,500 shares were traded during trading, a decline of 71% from the average session volume of 92,632 shares. The stock had previously closed […]

Viridium Pacific Group Ltd (CVE:VIR – Get Free Report)’s stock price traded up 5.6% during trading on Wednesday . The company traded as high as C$0.41 and last traded at C$0.38. 26,500 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 92,632 shares. The stock had previously closed […]

By Ben Glickman Vir Biotechnology will cut about 12% of its workforce and close two research facilities as it looks to slash operating costs. The San...

At a VIR seminar on December 4, in collaboration with Agribank, key stakeholders congregated to discuss Lighting the Path for Green Financing.